TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Tg Therapeutics, Inc.
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit

TG Therapeutics' CEO Michael S. Weiss will participate in a virtual fireside chat at the TD Cowen Immunology & Inflammation Summit on November 12, 2025, discussing the company's developments in B-cell disease treatments.

Insights
DELL   positive

Secured $5.8B GPU supply agreement, supporting Iren's infrastructure expansion


TGTX   positive

Company has FDA approval for BRIUMVI, raised full-year revenue guidance to $600 million, and is actively presenting at industry conferences, indicating strong market performance and growth potential